Other
Long-term debt, gross
ResMed Long-term debt, gross remained flat by 0.0% to $405.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 39.1%, from $665.00M to $405.00M. Over 4 years (FY 2021 to FY 2025), Long-term debt, gross shows relatively stable performance with a 0.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ2 2025
Last reportedQ1 2026
How to read this metric
A decrease indicates deleveraging, which generally reduces financial risk, while an increase may signal expansion or acquisition financing.
Detailed definition
This represents the total principal amount of long-term debt obligations carried on the balance sheet, excluding short-t...
Peer comparison
Standard metric for all capital-intensive firms; essential for calculating debt-to-equity and net debt ratios.
Metric ID:
other_debt_instrument_carrying_amountHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $646.00M | $796.00M | $670.00M | $670.00M | $770.00M | $790.00M | $1.80B | $1.58B | $1.44B | $1.36B | $1.22B | $1.00B | $700.00M | $670.00M | $665.00M | $665.00M | $660.00M | $410.00M | $405.00M | $405.00M |
| QoQ Change | — | +23.2% | -15.8% | +0.0% | +14.9% | +2.6% | +127.2% | -12.0% | -9.2% | -5.6% | -10.0% | -18.0% | -30.0% | -4.3% | -0.7% | +0.0% | -0.8% | -37.9% | -1.2% | +0.0% |
| YoY Change | — | — | — | — | +19.2% | -0.8% | +167.9% | +135.8% | +86.4% | +71.5% | -32.0% | -36.7% | -51.2% | -50.6% | -45.5% | -33.5% | -5.7% | -38.8% | -39.1% | -39.1% |
Range$405.00M – $1.80B
CAGR-9.4%
Avg YoY Growth+6.7%
Median YoY Growth-32.8%
Long-term debt, gross at Other Companies
Frequently Asked Questions
- What is ResMed's long-term debt, gross?
- ResMed (RMD) reported long-term debt, gross of $405.00M in Q1 2026.
- How has ResMed's long-term debt, gross changed year-over-year?
- ResMed's long-term debt, gross decreased by 39.1% year-over-year, from $665.00M to $405.00M.
- What is the long-term trend for ResMed's long-term debt, gross?
- Over 4 years (2021 to 2025), ResMed's long-term debt, gross has grown at a 0.5% compound annual growth rate (CAGR), from $646.00M to $660.00M.
- What does long-term debt, gross mean?
- The total amount of long-term debt the company owes to creditors.